| Title |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
|
|---|---|
| Published in |
Clinical Pharmacology & Therapeutics, June 2015
|
| DOI | 10.1002/cpt.113 |
| Pubmed ID | |
| Authors |
K A Birdwell, B Decker, J M Barbarino, J F Peterson, C M Stein, W Sadee, D Wang, A A Vinks, Y He, J J Swen, J S Leeder, Rhn van Schaik, K E Thummel, T E Klein, K E Caudle, I A M MacPhee |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 36% |
| Venezuela, Bolivarian Republic of | 1 | 7% |
| United States | 1 | 7% |
| Unknown | 7 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 43% |
| Practitioners (doctors, other healthcare professionals) | 5 | 36% |
| Scientists | 1 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
| Unknown | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 306 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| India | 1 | <1% |
| France | 1 | <1% |
| Unknown | 302 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 48 | 16% |
| Student > Ph. D. Student | 40 | 13% |
| Student > Master | 28 | 9% |
| Student > Bachelor | 27 | 9% |
| Other | 22 | 7% |
| Other | 50 | 16% |
| Unknown | 91 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 67 | 22% |
| Medicine and Dentistry | 62 | 20% |
| Biochemistry, Genetics and Molecular Biology | 39 | 13% |
| Agricultural and Biological Sciences | 17 | 6% |
| Nursing and Health Professions | 5 | 2% |
| Other | 20 | 7% |
| Unknown | 96 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2020.
All research outputs
#1,592,508
of 26,017,215 outputs
Outputs from Clinical Pharmacology & Therapeutics
#225
of 4,619 outputs
Outputs of similar age
#19,538
of 283,896 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#4
of 30 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,619 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,896 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.